Inquiry Basket
Catalog | Product Name | CAS Number |
---|---|---|
BADC-00447 | Mal-amido-PEG2-NHS | 955094-26-5 |
Mal-amido-PEG2-NHS is a non-cleavable ADC linker containing the Maleimide group, 2-unit PEG, and NHS ester. | Inquiry | |
BADC-00448 | Mal-PEG-NHS | 1260092-50-9 |
Mal-PEG-NHS is a bioconjugation reagent widely used in the biomedical industry. It is a maleimide-functionalized polyethylene glycol derivative with an NHS ester group at the other end. This compound is commonly utilized for the selective modification of proteins, peptides, and other biomolecules. It enables the conjugation of amine-containing drugs or targeting ligands to various disease-specific proteins or surfaces, thus facilitating targeted drug delivery and diagnostics. | Inquiry | |
BADC-00449 | Mal-PEG4-PFP | 1415800-42-8 |
Mal-PEG4-PFP ester is a PEG linker containing maleimide and PFP moieties. Maleimide is thiol-reactive and reacts between pH 6.5 and 7.5 to form thiol ester bonds. PFP moiety is amine-reactive and is less susceptible to undergoing hydrolysis. The hydrophilic PEG linker increases the water solubility of a compound in aqueous media. | Inquiry | |
BADC-00450 | Mal-PEG4-NHS | 1325208-25-0 |
Mal-PEG4-NHS is a non-cleavable ADC linker containing the Maleimide group, 4-unit PEG, and NHS ester. | Inquiry | |
BADC-00451 | 2,5-dioxopyrrolidin-1-yl 2-(2-(2-(2-(2,5-dioxo-2H-pyrrol-1(5H)-yl)ethoxy)ethoxy)ethoxy)acetate | |
2,5-dioxopyrrolidin-1-yl 2-(2-(2-(2-(2,5-dioxo-2H-pyrrol-1(5H)-yl)ethoxy)ethoxy)ethoxy)acetate is a biomedical compound. Characterized by its complex molecular composition, it can be used as a candidate active ingredient for therapeutic intervention in a variety of diseases. Furthermore, it has potential use in the field of cancer treatment, as it disrupts the metabolic processes of malignant cells. | Inquiry | |
BADC-00452 | Mal-PEG2-PFP | 1807512-47-5 |
Mal-PEG2-PFP is a PEG linker containing maleimide and PFP moieties. Maleimide is thiol-reactive and reacts between pH 6.5 and 7.5 to form thiol ester bonds. PFP moiety is amine-reactive and is less susceptible to undergoing hydrolysis. The hydrophilic PEG linker increases the water solubility of a compound in aqueous media. | Inquiry | |
BADC-00453 | Mal-PEG2-NHS | 1433997-01-3 |
Mal-PEG2-NHS is a non-cleavable ADC linker containing the Maleimide group, 2-unit PEG, and NHS ester. | Inquiry | |
BADC-00455 | 1-((1r,4r)-4-((2,5-dioxo-2H-pyrrol-1(5H)-yl)methyl)cyclohexanecarbonyloxy)-2,5-dioxopyrrolidine-3-sulfonic acid | 1286837-77-1 |
1-((1R,4R)-4-((2,5-dioxo-2H-pyrrol-1(5H)-yl)methyl)cyclohexanecarbonyloxy)-2,5-dioxopyrrolidine-3-sulfonic acid is an immensely potent pharmaceutical agent. Conspicuously, it demonstrates efficacy in combating diverse afflictions such as cancer and autoimmune disorders. Capitalizing on its distinct molecular configuration, it exhibits targeted activity on specific biological pathways, thereby ushering in novel prospects for efficacious therapeutic interventions. | Inquiry | |
BADC-00461 | 4-succinimidyl-oxycarbonyl-α-(2-pyridyldithio)toluene | 160854-54-6 |
Inquiry | ||
BADC-00462 | SMPT | 112241-19-7 |
Inquiry | ||
BADC-00496 | succimimidyl-4-azidobutyrate | 943858-70-6 |
Succimimidyl-4-azidobutyrate is a superior biopharmaceutical formulation that can facilitate breakthrough drug development and research efforts. As a chemically mediated linker, it accelerates the synthesis of targeted drugs, ultimately resulting in good precision in drug delivery and modulated drug release. | Inquiry | |
BADC-00498 | Propargyl-NHS Ester | 1174157-65-3 |
Propargyl-NHS ester is an indispensable small molecule tool in the biomedical field and is a key coupling agent that promotes bioconjugation reactions. This compound labels a range of biomolecules including proteins and peptides, facilitating their unambiguous identification and meticulous monitoring. With its sheer versatility, Propargyl-NHS Ester coordinates a range of tasks, including drug delivery systems, diagnostics and targeted therapies. | Inquiry | |
BADC-00499 | Mal-PEG6-NHS ester | 1599472-25-9 |
Mal-PEG6-NHS ester is a non-cleavable ADC linker containing the Maleimide group, 6-unit PEG, and NHS ester. | Inquiry | |
BADC-01935 | Methyl (2R,4R)-4-hydroxypyrrolidine-2-carboxylate hydrochloride | 114676-59-4 |
Methyl (2R,4R)-4-hydroxypyrrolidine-2-carboxylate hydrochloride is a non-cleavable ADC linker and also an alkyl chain-based PROTAC linker. | Inquiry | |
BADC-00505 | 6-Maleimidocaproic acid sulfo-NHS | 103848-61-9 |
6-Maleimidocaproic acid sulfo-NHS is a small molecule reagent used in the biomedical industry. It is commonly used to modify biomolecules, such as proteins and antibodies, for site-specific conjugation. This compound enables the efficient and stable attachment of drugs, tags, or targeting moieties to these biomolecules, thereby facilitating the development of innovative treatments for a variety of diseases, including cancer and autoimmune diseases. | Inquiry | |
BADC-01943 | FMOC-L-HYP(BOM)-OH | 187223-15-0 |
Fmoc-Hyp(Bom)-OH is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry | |
BADC-00502 | ATFB-SE | 126695-58-7 |
ATFB-SE is an ADC non-cleavable linker with breakthrough potential in the field of drug release carriers and targeted therapy. It can be used for biomolecule, protein and peptide labeling. | Inquiry | |
BADC-00509 | MTS-4-NHS | 690632-55-4 |
Inquiry | ||
BADC-00508 | SPDPH | 158913-22-5 |
SPDPH is a biochemical product used in cancer drug development. It acts as a linker moiety for attaching biomolecules to surfaces or to each other. The product plays a key role in drug delivery systems, cancer diagnostics and targeted therapies. SPDPH enables the targeted delivery of drugs and diagnostics, thereby increasing the efficacy and specificity of cancer treatments. | Inquiry | |
BADC-01916 | 20-(tert-Butoxy)-20-oxoicosanoic acid | 683239-16-9 |
20-(tert-Butoxy)-20-oxoicosanoic acid is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). | Inquiry |